Bleeding, Thrombosis and Vascular Biology
PAGEPress Publications
About the journal
Bleeding, Thrombosis and Vascular Biology is an open-access journal published by PAGEPress Publications in Italy, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 14 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- PAGEPress Publications
- ISSN
- 2785-5309
- Country
- Italy
- Languages
- english
- Access
- Open access
- Articles in DOAJ
- 458
- Declared review time
- 14 weeks
- Declared peer-review model
- peer_review
- Official website
- https://btvb.org/btvb
Index listings
- DOAJ · 2023-03-23
- Indexing
- DOAJ
- APC
- —
- Declared review time (DOAJ)
- 14 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
458
Most recent article
last month
Average review time (journal-declared via DOAJ)
14weeks
Works in OpenAlex
432
Last recorded publication year
2026
h-index
4
i10-index
0
From OpenAlex open data (CC0).
Editorial & policy10
- Last DOAJ review date
- 2023-03-23
- Added to DOAJ
- 2023-03-23
- Declared plagiarism screening
- Not declared
- Other fees beyond APC
- No
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- PKP PNPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 79%
- ORCID iDs in current deposits
- 20%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9918822487406676
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Venous Thromboembolism Diagnosis and Management
- Venous Thromboembolism Diagnosis and Management
- Hemophilia Treatment and Research
- Hemophilia Treatment and Research
- Platelet Disorders and Treatments
- Atrial Fibrillation Management and Outcomes
- Blood Coagulation and Thrombosis Mechanisms
- Platelet Disorders and Treatments
Show all subjects (50)
- Atrial Fibrillation Management and Outcomes
- Blood Coagulation and Thrombosis Mechanisms
- Heparin-Induced Thrombocytopenia and Thrombosis
- Heparin-Induced Thrombocytopenia and Thrombosis
- Antiplatelet Therapy and Cardiovascular Diseases
- Antiplatelet Therapy and Cardiovascular Diseases
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Blood properties and coagulation
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Blood properties and coagulation
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Inflammatory Biomarkers in Disease Prognosis
- Inflammatory Biomarkers in Disease Prognosis
- Chronic Myeloid Leukemia Treatments
- Chronic Myeloid Leukemia Treatments
- Cardiac tumors and thrombi
- Cardiac tumors and thrombi
- Central Venous Catheters and Hemodialysis
- Acute Ischemic Stroke Management
- Central Venous Catheters and Hemodialysis
- Acute Ischemic Stroke Management
- Chemotherapy-induced cardiotoxicity and mitigation
- Peripheral Artery Disease Management
- Chemotherapy-induced cardiotoxicity and mitigation
- Cerebral Venous Sinus Thrombosis
- Cerebral Venous Sinus Thrombosis
- Peripheral Artery Disease Management
- Systemic Lupus Erythematosus Research
- Hepatocellular Carcinoma Treatment and Prognosis
- Systemic Lupus Erythematosus Research
- Acute Myocardial Infarction Research
- Hepatocellular Carcinoma Treatment and Prognosis
- Acute Myocardial Infarction Research
- Lipoproteins and Cardiovascular Health
- Complement system in diseases
- Protease and Inhibitor Mechanisms
- Lipoproteins and Cardiovascular Health
- Complement system in diseases
- Adipokines, Inflammation, and Metabolic Diseases
- Adipokines, Inflammation, and Metabolic Diseases
- Hemoglobinopathies and Related Disorders
Keywords (DOAJ)
- vascular biology
- thrombotic diseases
- hemorrhagic diseases
- blood coagulation disorders
- fibrinolysis
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ